课题基金 / 基金详情

POSTMENOPAUSAL OSTEOPOROSIS

POSTMENOPAUSAL OSTEOPOROSIS
绝经后骨质疏松症
批准号:
6265511
负责人:
NORMAN L BELL
金额:
$1.74万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

NORMAN L BELL的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究旨在比较两种药物的疗效。福善美(阿仑磷酸钠片剂)和米卡林(降钙素-鲑鱼)鼻喷雾剂。目前在美国用于治疗绝经后骨质疏松症的处方,并评估其治疗的安全性和耐受性。如果需要,所有患者还将接受维生素D和钙补充剂。钙是健康骨骼所必需的营养物质;许多临床研究表明,增加钙的摄入量可能会保护骨骼免受进一步的骨质流失。大约320名绝经后妇女将进入这项研究。
英文摘要
This study is designed to compare the effectiveness of two medications. Fosamax (alendronate sodium tablets) and Miacalcin (calcitonin-salmon) Nasal Spray. Currently prescribed in the United States for treatment of postmenopausal osteoporosis, and to assess safety and tolerability of their treatments. All patients will also receive Vitamin D and calcium supplements, if needed. Calcium is an essential nutrient for healthy bones; many clinical studies have shown that increasing calcium intake may protect the skeleton from further bone loss. Approximately 320 postmenopausal women will be entered into this study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TESTOSTERONE DEFICIENCY & BONE LOSS
POSTMENOPAUSAL OSTEOPOROSIS
POSTMENOPAUSAL OSTEOPOROSIS
POSTMENOPAUSAL OSTEOPOROSIS
国内基金
海外基金
降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
  • 批准号:
    81873385
  • 项目类别:
    面上项目
  • 资助金额:
    59.0万元
  • 批准年份:
    2018
  • 负责人:
    乔海法
  • 依托单位: